

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.08670798 |
| 2 | actin-mediated cell contraction (GO:0070252) | 8.62667683 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 7.97192453 |
| 4 | myofibril assembly (GO:0030239) | 7.94578136 |
| 5 | cardiac myofibril assembly (GO:0055003) | 7.94160225 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.19689903 |
| 7 | cardiac muscle contraction (GO:0060048) | 6.76106381 |
| 8 | actin filament-based movement (GO:0030048) | 6.37371336 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.36264112 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.31420367 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.26474057 |
| 12 | * striated muscle contraction (GO:0006941) | 6.14408832 |
| 13 | plasma membrane repair (GO:0001778) | 6.12877652 |
| 14 | cardiac muscle cell development (GO:0055013) | 6.08217991 |
| 15 | tricarboxylic acid cycle (GO:0006099) | 6.02016109 |
| 16 | actomyosin structure organization (GO:0031032) | 6.00810694 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.94120106 |
| 18 | skeletal muscle contraction (GO:0003009) | 5.79702363 |
| 19 | heart contraction (GO:0060047) | 5.78235971 |
| 20 | heart process (GO:0003015) | 5.78235971 |
| 21 | skeletal muscle fiber development (GO:0048741) | 5.74344737 |
| 22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.72757967 |
| 23 | cardiac cell development (GO:0055006) | 5.72021454 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.56587411 |
| 25 | carnitine shuttle (GO:0006853) | 5.28581812 |
| 26 | muscle tissue morphogenesis (GO:0060415) | 5.26878866 |
| 27 | cardiac muscle hypertrophy (GO:0003300) | 5.24662177 |
| 28 | myotube cell development (GO:0014904) | 5.20711687 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 5.16640956 |
| 30 | striated muscle hypertrophy (GO:0014897) | 5.08809002 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.99805843 |
| 32 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.94672223 |
| 33 | adult heart development (GO:0007512) | 4.87643130 |
| 34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.85538337 |
| 35 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.85325039 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 4.84907168 |
| 37 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.82651625 |
| 38 | regulation of sarcomere organization (GO:0060297) | 4.72274706 |
| 39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.71395585 |
| 40 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.70814645 |
| 41 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.55729654 |
| 42 | glucan biosynthetic process (GO:0009250) | 4.54072947 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.53743188 |
| 44 | muscle cell cellular homeostasis (GO:0046716) | 4.53169014 |
| 45 | muscle hypertrophy (GO:0014896) | 4.49096691 |
| 46 | carnitine transmembrane transport (GO:1902603) | 4.45717489 |
| 47 | heart trabecula formation (GO:0060347) | 4.45555227 |
| 48 | fatty acid transmembrane transport (GO:1902001) | 4.44511887 |
| 49 | skeletal muscle adaptation (GO:0043501) | 4.41154005 |
| 50 | oxidative phosphorylation (GO:0006119) | 4.36744461 |
| 51 | skeletal muscle tissue development (GO:0007519) | 4.34040027 |
| 52 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.33304911 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 4.33304911 |
| 54 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.30125038 |
| 55 | * muscle contraction (GO:0006936) | 4.28187287 |
| 56 | response to inactivity (GO:0014854) | 4.25783354 |
| 57 | amino-acid betaine transport (GO:0015838) | 4.18569148 |
| 58 | carnitine transport (GO:0015879) | 4.18569148 |
| 59 | regulation of cofactor metabolic process (GO:0051193) | 4.18336888 |
| 60 | regulation of coenzyme metabolic process (GO:0051196) | 4.18336888 |
| 61 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.11858888 |
| 62 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.11642889 |
| 63 | regulation of the force of heart contraction (GO:0002026) | 4.11205967 |
| 64 | striated muscle atrophy (GO:0014891) | 4.04369536 |
| 65 | striated muscle cell development (GO:0055002) | 4.02485346 |
| 66 | cytidine deamination (GO:0009972) | 4.01627065 |
| 67 | cytidine metabolic process (GO:0046087) | 4.01627065 |
| 68 | cytidine catabolic process (GO:0006216) | 4.01627065 |
| 69 | polysaccharide catabolic process (GO:0000272) | 3.99480710 |
| 70 | skeletal muscle tissue regeneration (GO:0043403) | 3.95185904 |
| 71 | respiratory electron transport chain (GO:0022904) | 3.95056926 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92268603 |
| 73 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.92249790 |
| 74 | creatine metabolic process (GO:0006600) | 3.91990544 |
| 75 | regulation of membrane repolarization (GO:0060306) | 3.91742870 |
| 76 | * muscle system process (GO:0003012) | 3.91662392 |
| 77 | striated muscle adaptation (GO:0014888) | 3.86425449 |
| 78 | electron transport chain (GO:0022900) | 3.86405520 |
| 79 | glycogen metabolic process (GO:0005977) | 3.85964250 |
| 80 | muscle adaptation (GO:0043500) | 3.83627788 |
| 81 | regulation of ATP catabolic process (GO:1903289) | 3.81142643 |
| 82 | regulation of ATPase activity (GO:0043462) | 3.81142643 |
| 83 | negative regulation of protein localization to cell surface (GO:2000009) | 3.80003998 |
| 84 | fructose metabolic process (GO:0006000) | 3.79042628 |
| 85 | cellular glucan metabolic process (GO:0006073) | 3.78591954 |
| 86 | glucan metabolic process (GO:0044042) | 3.78591954 |
| 87 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.77756265 |
| 88 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.77756265 |
| 89 | muscle hypertrophy in response to stress (GO:0003299) | 3.75067070 |
| 90 | cardiac muscle adaptation (GO:0014887) | 3.75067070 |
| 91 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.75067070 |
| 92 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.73806607 |
| 93 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.72933207 |
| 94 | response to activity (GO:0014823) | 3.72442205 |
| 95 | muscle atrophy (GO:0014889) | 3.69562433 |
| 96 | muscle cell fate commitment (GO:0042693) | 3.69377798 |
| 97 | glycogen catabolic process (GO:0005980) | 3.69259919 |
| 98 | muscle organ development (GO:0007517) | 3.68275264 |
| 99 | muscle structure development (GO:0061061) | 3.67673151 |
| 100 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.62424244 |
| 101 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.62424244 |
| 102 | regulation of cardioblast differentiation (GO:0051890) | 3.61887416 |
| 103 | muscle fiber development (GO:0048747) | 3.60683963 |
| 104 | response to muscle activity (GO:0014850) | 3.57032581 |
| 105 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.54785907 |
| 106 | regulation of myoblast differentiation (GO:0045661) | 3.49798244 |
| 107 | positive regulation of myotube differentiation (GO:0010831) | 3.47837560 |
| 108 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.44220493 |
| 109 | muscle cell development (GO:0055001) | 3.44039923 |
| 110 | glucan catabolic process (GO:0009251) | 3.43571657 |
| 111 | ATP biosynthetic process (GO:0006754) | 3.40057616 |
| 112 | positive regulation of cation channel activity (GO:2001259) | 3.39063493 |
| 113 | regulation of muscle contraction (GO:0006937) | 3.36975546 |
| 114 | NADH metabolic process (GO:0006734) | 3.36043204 |
| 115 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.35979922 |
| 116 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.34338562 |
| 117 | relaxation of muscle (GO:0090075) | 3.33523879 |
| 118 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.33427138 |
| 119 | regulation of muscle system process (GO:0090257) | 3.32859268 |
| 120 | regulation of sulfur metabolic process (GO:0042762) | 3.32360253 |
| 121 | negative regulation of potassium ion transport (GO:0043267) | 3.29430871 |
| 122 | AMP metabolic process (GO:0046033) | 3.26426373 |
| 123 | negative regulation of muscle hypertrophy (GO:0014741) | 3.25245494 |
| 124 | ventricular cardiac muscle cell development (GO:0055015) | 3.23784452 |
| 125 | regulation of heart rate (GO:0002027) | 3.22609281 |
| 126 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.22039118 |
| 127 | cellular polysaccharide catabolic process (GO:0044247) | 3.21210237 |
| 128 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20128399 |
| 129 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.20003317 |
| 130 | glycogen biosynthetic process (GO:0005978) | 3.19805630 |
| 131 | muscle organ morphogenesis (GO:0048644) | 3.14094477 |
| 132 | * gluconeogenesis (GO:0006094) | 3.13883741 |
| 133 | striated muscle tissue development (GO:0014706) | 3.12683909 |
| 134 | muscle filament sliding (GO:0030049) | 10.4167694 |
| 135 | actin-myosin filament sliding (GO:0033275) | 10.4167694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.37859958 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.76697492 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.49542652 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.49469474 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.91527708 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.91527708 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.64792993 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.48434660 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.26898772 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.86844426 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.83136341 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.79371631 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.71975200 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.38620508 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.33537919 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32370279 |
| 17 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.27434922 |
| 18 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.12450658 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07383796 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02304030 |
| 21 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.95618411 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94909306 |
| 23 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.85228847 |
| 24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.76339363 |
| 25 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63435321 |
| 26 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.62020726 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56189304 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55556280 |
| 29 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.49034490 |
| 30 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.48424770 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45204742 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42871242 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37458416 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34443451 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29461771 |
| 36 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.29102662 |
| 37 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.28738130 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28053085 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27734880 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22270130 |
| 41 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.20953865 |
| 42 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18324906 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17984663 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17707041 |
| 45 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.17153480 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16468490 |
| 47 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.13593139 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10763098 |
| 49 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10575804 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10436398 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09462790 |
| 52 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.07661404 |
| 53 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07384452 |
| 54 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.07343072 |
| 55 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03466120 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02357588 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02308854 |
| 58 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.01796451 |
| 59 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.00563567 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00559318 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00490829 |
| 62 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.00169655 |
| 63 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99658649 |
| 64 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.98851362 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98577467 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98195946 |
| 67 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97845115 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95726146 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95411436 |
| 70 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95070700 |
| 71 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.94167112 |
| 72 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.93722852 |
| 73 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93624631 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93572824 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92676155 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92223171 |
| 77 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.91558646 |
| 78 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.91100651 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88730374 |
| 80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88468992 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86990789 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.86585954 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85919097 |
| 84 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85786487 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84063252 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84032974 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83953192 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83377809 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82735636 |
| 90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82586436 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82586436 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82224342 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82078919 |
| 94 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.81938619 |
| 95 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81451427 |
| 96 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81216134 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81010251 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81005998 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80950937 |
| 100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.80945154 |
| 101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80248429 |
| 102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80037991 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79863393 |
| 104 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.79412031 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79364947 |
| 106 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79226901 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79127245 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78418218 |
| 109 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.77928867 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77675108 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.77655575 |
| 112 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.77640607 |
| 113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.77356110 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76799579 |
| 115 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.76205141 |
| 116 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.76205141 |
| 117 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76085996 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75938426 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.75787037 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75483150 |
| 121 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.75443398 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75408150 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75263318 |
| 124 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.74866870 |
| 125 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.74038869 |
| 126 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.73966675 |
| 127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73961385 |
| 128 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73850667 |
| 129 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73821934 |
| 130 | ERA_21632823_ChIP-Seq_H3396_Human | 0.73403817 |
| 131 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.72975340 |
| 132 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.72972452 |
| 133 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72905611 |
| 134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72418969 |
| 135 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.72277524 |
| 136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72065143 |
| 137 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71699789 |
| 138 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71454380 |
| 139 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.71377380 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71134381 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70894191 |
| 142 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.70696167 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.70659791 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70196677 |
| 145 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.70092376 |
| 146 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.69993316 |
| 147 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.68615467 |
| 148 | SA1_27219007_Chip-Seq_Bcells_Human | 0.68565227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.94850783 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.57023327 |
| 3 | MP0000749_muscle_degeneration | 5.47912085 |
| 4 | MP0000751_myopathy | 5.27927379 |
| 5 | MP0004084_abnormal_cardiac_muscle | 4.98810319 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.64934700 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 4.44077829 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.60432078 |
| 9 | MP0005330_cardiomyopathy | 3.47973433 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.43817400 |
| 11 | MP0002106_abnormal_muscle_physiology | 3.24808985 |
| 12 | MP0005620_abnormal_muscle_contractility | 3.09134182 |
| 13 | MP0002269_muscular_atrophy | 2.97114507 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.89921710 |
| 15 | MP0000747_muscle_weakness | 2.87244482 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.82111531 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.64578763 |
| 18 | MP0005369_muscle_phenotype | 2.63465921 |
| 19 | MP0004130_abnormal_muscle_cell | 2.44095120 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.42103584 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.41295410 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.25916766 |
| 23 | MP0004233_abnormal_muscle_weight | 2.24032699 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.23171970 |
| 25 | MP0005385_cardiovascular_system_phenoty | 2.23171970 |
| 26 | MP0004484_altered_response_of | 2.13086283 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 2.07010981 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 2.06369332 |
| 29 | MP0005410_abnormal_fertilization | 1.99013605 |
| 30 | MP0006138_congestive_heart_failure | 1.98370570 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.80283360 |
| 32 | MP0004085_abnormal_heartbeat | 1.69847996 |
| 33 | MP0003828_pulmonary_edema | 1.68435362 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.67289097 |
| 35 | MP0004510_myositis | 1.61396649 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.59758520 |
| 37 | MP0005670_abnormal_white_adipose | 1.29535364 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.23114274 |
| 39 | MP0004270_analgesia | 1.22479080 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.20624103 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19708674 |
| 42 | MP0002234_abnormal_pharynx_morphology | 1.16373718 |
| 43 | MP0005451_abnormal_body_composition | 1.15567977 |
| 44 | MP0002108_abnormal_muscle_morphology | 1.14929820 |
| 45 | MP0000733_abnormal_muscle_development | 1.11871269 |
| 46 | MP0000266_abnormal_heart_morphology | 1.06812121 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 0.96009782 |
| 48 | MP0005266_abnormal_metabolism | 0.90916193 |
| 49 | MP0001661_extended_life_span | 0.89853706 |
| 50 | MP0000343_altered_response_to | 0.88633927 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 0.82387518 |
| 52 | MP0002822_catalepsy | 0.77779564 |
| 53 | MP0005375_adipose_tissue_phenotype | 0.76505879 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 0.74076153 |
| 55 | MP0003279_aneurysm | 0.72928903 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.67895392 |
| 57 | MP0002971_abnormal_brown_adipose | 0.66486390 |
| 58 | MP0002128_abnormal_blood_circulation | 0.63192830 |
| 59 | MP0004043_abnormal_pH_regulation | 0.60333547 |
| 60 | MP0003045_fibrosis | 0.57493520 |
| 61 | MP0005165_increased_susceptibility_to | 0.57040957 |
| 62 | MP0005623_abnormal_meninges_morphology | 0.54547505 |
| 63 | MP0003879_abnormal_hair_cell | 0.51856268 |
| 64 | MP0003698_abnormal_male_reproductive | 0.51758146 |
| 65 | MP0010368_abnormal_lymphatic_system | 0.51188370 |
| 66 | MP0003566_abnormal_cell_adhesion | 0.49660581 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.48481667 |
| 68 | MP0001299_abnormal_eye_distance/ | 0.48363732 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.46599379 |
| 70 | MP0008569_lethality_at_weaning | 0.44135152 |
| 71 | MP0001879_abnormal_lymphatic_vessel | 0.43952114 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.43727902 |
| 73 | MP0002925_abnormal_cardiovascular_devel | 0.43359145 |
| 74 | MP0000372_irregular_coat_pigmentation | 0.42699338 |
| 75 | MP0004272_abnormal_basement_membrane | 0.42567006 |
| 76 | MP0005275_abnormal_skin_tensile | 0.42479976 |
| 77 | MP0003984_embryonic_growth_retardation | 0.41576352 |
| 78 | MP0002088_abnormal_embryonic_growth/wei | 0.41310356 |
| 79 | MP0003948_abnormal_gas_homeostasis | 0.39216851 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.39107307 |
| 81 | MP0001929_abnormal_gametogenesis | 0.39000317 |
| 82 | MP0009840_abnormal_foam_cell | 0.38952522 |
| 83 | MP0004134_abnormal_chest_morphology | 0.37676074 |
| 84 | MP0004147_increased_porphyrin_level | 0.37508606 |
| 85 | MP0000767_abnormal_smooth_muscle | 0.37420364 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.37219121 |
| 87 | MP0005166_decreased_susceptibility_to | 0.37202309 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.37016144 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.36818578 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.36623214 |
| 91 | MP0001784_abnormal_fluid_regulation | 0.35891287 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.34804152 |
| 93 | MP0001614_abnormal_blood_vessel | 0.30892049 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.30404583 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.29217474 |
| 96 | MP0003941_abnormal_skin_development | 0.27038898 |
| 97 | MP0004142_abnormal_muscle_tone | 0.27007428 |
| 98 | MP0005083_abnormal_biliary_tract | 0.26838990 |
| 99 | MP0005423_abnormal_somatic_nervous | 0.26011257 |
| 100 | MP0003122_maternal_imprinting | 0.25534584 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.25416915 |
| 102 | MP0002114_abnormal_axial_skeleton | 0.25200915 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.25139179 |
| 104 | MP0008004_abnormal_stomach_pH | 0.25070026 |
| 105 | MP0001727_abnormal_embryo_implantation | 0.24275200 |
| 106 | MP0003385_abnormal_body_wall | 0.23194324 |
| 107 | MP0005332_abnormal_amino_acid | 0.22730552 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.22512024 |
| 109 | MP0009250_abnormal_appendicular_skeleto | 0.22455465 |
| 110 | MP0001984_abnormal_olfaction | 0.22135921 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 0.21669275 |
| 112 | MP0005334_abnormal_fat_pad | 0.21597618 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.21473174 |
| 114 | MP0005380_embryogenesis_phenotype | 0.21348106 |
| 115 | MP0001672_abnormal_embryogenesis/_devel | 0.21348106 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.21226846 |
| 117 | MP0000358_abnormal_cell_content/ | 0.20484976 |
| 118 | MP0009672_abnormal_birth_weight | 0.20155473 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.19949061 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.19854048 |
| 121 | MP0008877_abnormal_DNA_methylation | 0.19309502 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.18919513 |
| 123 | MP0005452_abnormal_adipose_tissue | 0.18860627 |
| 124 | MP0005535_abnormal_body_temperature | 0.18132478 |
| 125 | MP0005187_abnormal_penis_morphology | 0.18050599 |
| 126 | MP0001529_abnormal_vocalization | 0.17801667 |
| 127 | MP0001943_abnormal_respiration | 0.17685684 |
| 128 | MP0004924_abnormal_behavior | 0.17319088 |
| 129 | MP0005386_behavior/neurological_phenoty | 0.17319088 |
| 130 | MP0001346_abnormal_lacrimal_gland | 0.16666446 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.16642586 |
| 132 | MP0008874_decreased_physiological_sensi | 0.14566486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Calf muscle hypertrophy (HP:0008981) | 7.23765040 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.16115832 |
| 3 | * Exercise-induced muscle cramps (HP:0003710) | 7.00896886 |
| 4 | * Exercise-induced myalgia (HP:0003738) | 7.00476292 |
| 5 | Sudden death (HP:0001699) | 6.45862168 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 6.06114190 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.90124869 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.69656152 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.57481603 |
| 10 | Abnormality of the calf musculature (HP:0001430) | 5.36477418 |
| 11 | Nemaline bodies (HP:0003798) | 5.36364125 |
| 12 | Ventricular tachycardia (HP:0004756) | 5.33987134 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.25878802 |
| 14 | Subaortic stenosis (HP:0001682) | 5.25878802 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 5.09446768 |
| 16 | * Myoglobinuria (HP:0002913) | 5.04255903 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.80500029 |
| 18 | Difficulty running (HP:0009046) | 4.40206849 |
| 19 | Lipoatrophy (HP:0100578) | 4.38736278 |
| 20 | Atrial fibrillation (HP:0005110) | 4.38357545 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 4.13863261 |
| 22 | Increased connective tissue (HP:0009025) | 4.10449855 |
| 23 | Primary atrial arrhythmia (HP:0001692) | 4.06780131 |
| 24 | * Rhabdomyolysis (HP:0003201) | 4.01720273 |
| 25 | Distal arthrogryposis (HP:0005684) | 3.93996818 |
| 26 | Supraventricular tachycardia (HP:0004755) | 3.92900139 |
| 27 | Supraventricular arrhythmia (HP:0005115) | 3.83824150 |
| 28 | Muscle stiffness (HP:0003552) | 3.76121206 |
| 29 | Myotonia (HP:0002486) | 3.75906622 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.65815806 |
| 31 | Myopathic facies (HP:0002058) | 3.54355171 |
| 32 | Bundle branch block (HP:0011710) | 3.51305618 |
| 33 | Round ear (HP:0100830) | 3.41811713 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 3.39508543 |
| 35 | Neck muscle weakness (HP:0000467) | 3.33083505 |
| 36 | Palpitations (HP:0001962) | 3.30036516 |
| 37 | Difficulty climbing stairs (HP:0003551) | 3.27621188 |
| 38 | Ulnar deviation of the wrist (HP:0003049) | 3.19570155 |
| 39 | Prolonged QT interval (HP:0001657) | 3.16183528 |
| 40 | Syncope (HP:0001279) | 3.10198343 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.09187054 |
| 42 | Ventricular arrhythmia (HP:0004308) | 3.08405605 |
| 43 | Rimmed vacuoles (HP:0003805) | 3.06831132 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.96859223 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.95392381 |
| 46 | Heart block (HP:0012722) | 2.86029436 |
| 47 | Increased variability in muscle fiber diameter (HP:0003557) | 2.83810997 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 2.81321934 |
| 49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.78712028 |
| 50 | Abnormal atrioventricular conduction (HP:0005150) | 2.68491347 |
| 51 | Generalized muscle weakness (HP:0003324) | 2.68200714 |
| 52 | EMG: neuropathic changes (HP:0003445) | 2.66871651 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.64490566 |
| 54 | Left ventricular hypertrophy (HP:0001712) | 2.55570969 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.48616867 |
| 56 | Double outlet right ventricle (HP:0001719) | 2.45650266 |
| 57 | Congenital malformation of the right heart (HP:0011723) | 2.45650266 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.45092434 |
| 59 | Atrioventricular block (HP:0001678) | 2.40859542 |
| 60 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.38437833 |
| 61 | Calcaneovalgus deformity (HP:0001848) | 2.38257632 |
| 62 | Hepatic necrosis (HP:0002605) | 2.37355364 |
| 63 | Acute encephalopathy (HP:0006846) | 2.35108345 |
| 64 | Fetal akinesia sequence (HP:0001989) | 2.34031587 |
| 65 | Abnormal EKG (HP:0003115) | 2.33898653 |
| 66 | Absent phalangeal crease (HP:0006109) | 2.33362183 |
| 67 | Progressive macrocephaly (HP:0004481) | 2.30095820 |
| 68 | Muscular dystrophy (HP:0003560) | 2.29633156 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.29590457 |
| 70 | Slender build (HP:0001533) | 2.22546321 |
| 71 | Ragged-red muscle fibers (HP:0003200) | 2.20494288 |
| 72 | * Exercise intolerance (HP:0003546) | 2.20425656 |
| 73 | Gowers sign (HP:0003391) | 2.20175471 |
| 74 | Mitochondrial inheritance (HP:0001427) | 2.18356008 |
| 75 | Abnormality of the calcaneus (HP:0008364) | 2.15847028 |
| 76 | Palmoplantar keratoderma (HP:0000982) | 2.15747724 |
| 77 | Deformed tarsal bones (HP:0008119) | 2.13944050 |
| 78 | Frequent falls (HP:0002359) | 2.13352949 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.12078841 |
| 80 | Conjunctival hamartoma (HP:0100780) | 2.11323399 |
| 81 | Hip contracture (HP:0003273) | 2.10008947 |
| 82 | Increased CSF lactate (HP:0002490) | 2.09609580 |
| 83 | Limb-girdle muscle atrophy (HP:0003797) | 2.06927806 |
| 84 | Waddling gait (HP:0002515) | 2.06270348 |
| 85 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.00910522 |
| 86 | Lower limb amyotrophy (HP:0007210) | 2.00784907 |
| 87 | Abnormal finger flexion creases (HP:0006143) | 1.99760869 |
| 88 | Facial diplegia (HP:0001349) | 1.98829879 |
| 89 | Abnormality of the foot musculature (HP:0001436) | 1.98642805 |
| 90 | Abnormality of the neuromuscular junction (HP:0003398) | 1.97899474 |
| 91 | Fatigable weakness (HP:0003473) | 1.97899474 |
| 92 | Cerebral edema (HP:0002181) | 1.94440113 |
| 93 | Proximal amyotrophy (HP:0007126) | 1.91333173 |
| 94 | Increased muscle lipid content (HP:0009058) | 1.90211994 |
| 95 | Ketoacidosis (HP:0001993) | 1.90082171 |
| 96 | Foot dorsiflexor weakness (HP:0009027) | 1.87388069 |
| 97 | Scapular winging (HP:0003691) | 1.86763574 |
| 98 | Bulbar palsy (HP:0001283) | 1.84422795 |
| 99 | Progressive muscle weakness (HP:0003323) | 1.83845947 |
| 100 | Weak cry (HP:0001612) | 1.83037117 |
| 101 | Malignant hyperthermia (HP:0002047) | 1.81612937 |
| 102 | Pheochromocytoma (HP:0002666) | 1.81120231 |
| 103 | Hypoplastic ischia (HP:0003175) | 1.80687055 |
| 104 | Lactic acidosis (HP:0003128) | 1.80538667 |
| 105 | Increased serum pyruvate (HP:0003542) | 1.80063466 |
| 106 | Abnormality of glycolysis (HP:0004366) | 1.80063466 |
| 107 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.79858136 |
| 108 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.79858136 |
| 109 | Limb-girdle muscle weakness (HP:0003325) | 1.79828578 |
| 110 | Spinal rigidity (HP:0003306) | 1.79651581 |
| 111 | Shoulder girdle muscle weakness (HP:0003547) | 1.74937576 |
| 112 | Pelvic girdle muscle weakness (HP:0003749) | 1.73291092 |
| 113 | Hyperkalemia (HP:0002153) | 1.72837168 |
| 114 | Nonprogressive disorder (HP:0003680) | 1.69244487 |
| 115 | Steppage gait (HP:0003376) | 1.63670074 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 1.61462760 |
| 117 | Popliteal pterygium (HP:0009756) | 1.56566963 |
| 118 | Type 2 muscle fiber atrophy (HP:0003554) | 1.52411850 |
| 119 | Metatarsus adductus (HP:0001840) | 1.51412809 |
| 120 | Long clavicles (HP:0000890) | 1.49789963 |
| 121 | Paralysis (HP:0003470) | 1.48441185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.49890017 |
| 2 | TTN | 5.40945668 |
| 3 | PDK4 | 4.47542587 |
| 4 | PDK3 | 4.47542587 |
| 5 | PHKG2 | 4.01887037 |
| 6 | PHKG1 | 4.01887037 |
| 7 | MYLK | 3.36044365 |
| 8 | PDK2 | 2.78046080 |
| 9 | DMPK | 2.28879832 |
| 10 | PIK3CA | 2.28241308 |
| 11 | STK24 | 2.24775754 |
| 12 | PKN2 | 2.13242881 |
| 13 | NEK1 | 2.07435614 |
| 14 | MUSK | 2.01507665 |
| 15 | BCKDK | 1.97518468 |
| 16 | ZAK | 1.95684031 |
| 17 | PINK1 | 1.88611978 |
| 18 | LMTK2 | 1.85189872 |
| 19 | NME1 | 1.72798492 |
| 20 | TRIB3 | 1.67033643 |
| 21 | MAP2K3 | 1.56856657 |
| 22 | STK38L | 1.55896609 |
| 23 | PIK3CG | 1.49202616 |
| 24 | TESK1 | 1.46032549 |
| 25 | PRKD3 | 1.27489576 |
| 26 | MAP3K7 | 1.19267475 |
| 27 | WNK4 | 1.14886887 |
| 28 | TIE1 | 1.07806650 |
| 29 | EEF2K | 1.06983947 |
| 30 | MAPK12 | 1.05047271 |
| 31 | ILK | 1.02293053 |
| 32 | PTK2B | 1.01073272 |
| 33 | MARK1 | 0.99942530 |
| 34 | ICK | 0.94945049 |
| 35 | CCNB1 | 0.91152329 |
| 36 | TRPM7 | 0.83581205 |
| 37 | CDC42BPA | 0.82114897 |
| 38 | PRKAA1 | 0.81757540 |
| 39 | MAP3K3 | 0.78896047 |
| 40 | MOS | 0.78401659 |
| 41 | LIMK1 | 0.74932458 |
| 42 | PAK3 | 0.74778271 |
| 43 | STK38 | 0.73041037 |
| 44 | PRKAA2 | 0.72226354 |
| 45 | ROCK1 | 0.70797189 |
| 46 | STK39 | 0.70400409 |
| 47 | CAMK2D | 0.69926180 |
| 48 | MAP2K6 | 0.69198757 |
| 49 | PRKD1 | 0.69055454 |
| 50 | MAPKAPK3 | 0.69054892 |
| 51 | MAP3K5 | 0.68537981 |
| 52 | FLT3 | 0.68297703 |
| 53 | MAP3K13 | 0.60926944 |
| 54 | ERBB3 | 0.60623622 |
| 55 | GRK7 | 0.56485994 |
| 56 | MAP2K4 | 0.55166981 |
| 57 | STK4 | 0.54929432 |
| 58 | DAPK3 | 0.54356045 |
| 59 | NEK9 | 0.53669386 |
| 60 | WNK1 | 0.49423907 |
| 61 | MAPK4 | 0.49300824 |
| 62 | PKN1 | 0.47809138 |
| 63 | KSR2 | 0.46373279 |
| 64 | SGK3 | 0.44849272 |
| 65 | CAMK2B | 0.44410327 |
| 66 | CAMK2G | 0.41707745 |
| 67 | PRKACB | 0.40703838 |
| 68 | SGK2 | 0.40611264 |
| 69 | MAP3K1 | 0.40600029 |
| 70 | MAP2K1 | 0.39933048 |
| 71 | RIPK1 | 0.39717952 |
| 72 | ARAF | 0.37824281 |
| 73 | PDK1 | 0.36262351 |
| 74 | CAMK1 | 0.35187882 |
| 75 | AKT2 | 0.34646672 |
| 76 | CAMK2A | 0.33370362 |
| 77 | MAP3K10 | 0.30335551 |
| 78 | PRKACA | 0.29819551 |
| 79 | ROCK2 | 0.29733218 |
| 80 | RPS6KB1 | 0.29137924 |
| 81 | SGK223 | 0.28480719 |
| 82 | SGK494 | 0.28480719 |
| 83 | INSRR | 0.27903008 |
| 84 | PRKG1 | 0.26688944 |
| 85 | STK3 | 0.26429157 |
| 86 | PDPK1 | 0.25644697 |
| 87 | RPS6KL1 | 0.24725308 |
| 88 | RPS6KC1 | 0.24725308 |
| 89 | MAPK13 | 0.24704381 |
| 90 | CAMK4 | 0.23349883 |
| 91 | TBK1 | 0.22356113 |
| 92 | MAPK10 | 0.21072210 |
| 93 | MAPK11 | 0.19578134 |
| 94 | PRKACG | 0.19040250 |
| 95 | RPS6KA6 | 0.18793698 |
| 96 | MAP3K6 | 0.17577908 |
| 97 | KDR | 0.17178106 |
| 98 | MAP3K11 | 0.15630140 |
| 99 | MARK2 | 0.15404369 |
| 100 | PAK2 | 0.15272756 |
| 101 | PDGFRA | 0.15001173 |
| 102 | SGK1 | 0.14815628 |
| 103 | RPS6KA1 | 0.14212406 |
| 104 | DAPK2 | 0.13409287 |
| 105 | LATS2 | 0.12342650 |
| 106 | PRKG2 | 0.11860618 |
| 107 | RPS6KB2 | 0.11769578 |
| 108 | TAOK2 | 0.11763142 |
| 109 | TGFBR2 | 0.11541979 |
| 110 | MARK3 | 0.11529188 |
| 111 | RPS6KA3 | 0.11307188 |
| 112 | RAF1 | 0.11048665 |
| 113 | EPHB2 | 0.09263570 |
| 114 | MAP3K9 | 0.09236173 |
| 115 | DYRK1B | 0.08319756 |
| 116 | LATS1 | 0.08056517 |
| 117 | NME2 | 0.07906550 |
| 118 | FGFR1 | 0.07839010 |
| 119 | ZAP70 | 0.07501355 |
| 120 | BRAF | 0.07006591 |
| 121 | SIK1 | 0.06808736 |
| 122 | MTOR | 0.06012783 |
| 123 | PTK6 | 0.05909830 |
| 124 | PRKCQ | 0.05883735 |
| 125 | TAOK1 | 0.05256445 |
| 126 | EPHB1 | 0.04153719 |
| 127 | RPS6KA2 | 0.03926662 |
| 128 | MAPK7 | 0.03747867 |
| 129 | PRKCH | 0.03729713 |
| 130 | FER | 0.03127982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.62995179 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.09770987 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.93335603 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.63724577 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.58027626 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.53134851 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.40688999 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.13758332 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.65430234 |
| 10 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.56337952 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.54202459 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.44223083 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32091280 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.29803387 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24379865 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.23046493 |
| 17 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.19289120 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88621825 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73437783 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66424428 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59101080 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51801161 |
| 23 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.49208426 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42255927 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34207830 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32767603 |
| 27 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26378356 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23165005 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19705717 |
| 30 | Insulin resistance_Homo sapiens_hsa04931 | 1.12831282 |
| 31 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07568870 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00700350 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99720901 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97495373 |
| 35 | Tight junction_Homo sapiens_hsa04530 | 0.96466294 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93977517 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.91819632 |
| 38 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90888921 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88299036 |
| 40 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83145839 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81953015 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81347756 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78221490 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77821261 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70481547 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 0.68346237 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61334097 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59111076 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58904208 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58243213 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55286673 |
| 52 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53182339 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49317984 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 0.48020232 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.47621483 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39035596 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39023158 |
| 58 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.37682998 |
| 59 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37450714 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37185154 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36215989 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35955573 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35930484 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35047012 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34782164 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.33417232 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33151649 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32327643 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.32000019 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.31409909 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.30138485 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27945138 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27469345 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27355987 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26657354 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26506589 |
| 77 | Long-term depression_Homo sapiens_hsa04730 | 0.24455921 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23987314 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.23215784 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22044534 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21659482 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.21637960 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21461745 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21199777 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21173820 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20101193 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19378615 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.18617611 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17535302 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.16873844 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.16304616 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15061313 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14407800 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.13380983 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.12548128 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.12083075 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.11676746 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11446477 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10198944 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09858837 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.09853643 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.09837643 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.08875191 |
| 104 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08299929 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.07856489 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.07663942 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07049380 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07006006 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06809243 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03600589 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.00583995 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00404240 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00210838 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | -0.0265566 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0233406 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | -0.0126552 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | -0.0037378 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0014790 |

